Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rebel Hemp Company appears to have been a hemp-focused consumer brand or operating division of Hollister Biosciences, rather than a standalone drug-development biotech company. Public disclosures from 2019-2020 describe Rebel Hemp Company as Hollister's hemp division and associate it with commercial hemp products including the brewed beverage Rebel Tea and premium hemp pre-rolls. The available evidence indicates a cannabinoid wellness and lifestyle brand focused on consumer packaged goods, not a clinical-stage pharmaceutical pipeline. There is no evidence of therapeutic drug candidates, molecular targets, formal clinical programs, or a proprietary drug-discovery platform. Based on currently accessible public information, Rebel Hemp Company should be classified as a commercial hemp/cannabis brand with limited standalone corporate footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rebel Hemp Company.